系统性硬化症相关肺动脉高压的治疗进展
@article{LCBL41299, author = {轩池 朱 和 秀梅 刘}, title = {系统性硬化症相关肺动脉高压的治疗进展}, journal = {临床与病理杂志}, volume = {41}, number = {7}, year = {2020}, keywords = {}, abstract = {肺动脉高压(pulmonary arterial hypertension,PAH)是系统性硬化症(systemic sclerosis,SSc)肺部受累最常见的并发症之一,也是SSc患者最主要的死亡原因。近年来,随着各种新型靶向药物的应用以及治疗策略的改进,系统性硬化症相关肺动脉高压(systemic sclerosis-associated pulmonary arterial hypertension,SSc-PAH)患者的生存率有了明显的提升。}, url = {https://lcbl.amegroups.com/article/view/41299} }